Baxter International (BAX) Long-Term Investments (2010 - 2011)

Baxter International's (BAX) quarterly Long-Term Investments came in at $25.0 million in Q4 2011, up 19.05% year-on-year from $21.0 million in Q4 2010, and up 19.05% on a QoQ basis from $21.0 million in Q4 2010.

Baxter International (BAX) Long-Term Investments (2010 - 2011) Analysis & Trends

Baxter International (BAX) has 2 years of Long-Term Investments data on file, last reported at $25.0 million in Q4 2011.

  • On a quarterly basis, Long-Term Investments rose 19.05% year-over-year to $25.0 million in Q4 2011; TTM through Dec 2011 was $25.0 million, a 19.05% increase from a year earlier, with the FY2011 full-year figure at $25.0 million, up 19.05% from the prior year.
  • Long-Term Investments for Q4 2011 stood at $25.0 million, up from $21.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for BAX reached as high as $25.0 million in Q4 2011 and fell as low as $21.0 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 800.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 3.41 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 207.70 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 25.00 Mn
Dec 31, 2010 21.00 Mn